Weight Management
April 7, 2026
·
read
Cost of Weight Loss Medication in Singapore (2026): Ozempic, Wegovy, Mounjaro Pricing
Medically reviewed by Dr. Kevin Chua, Medical Director
Medically reviewed by Dr. Kevin Chua, Medical Director
Disclaimer: Prices are approximate and subject to change. Updated April 2026.
GLP-1 weight loss medications represent a significant financial commitment. Understanding the full cost picture — medication, consultations, monitoring, and hidden expenses — helps you budget appropriately and evaluate value for money. This guide provides transparent pricing for every major option available in Singapore.
Here's a comprehensive comparison of monthly medication costs across the major GLP-1 options currently available or becoming available in Singapore.
| Medication | Route | Monthly Cost (SGD) | Annual Cost (SGD) |
|---|---|---|---|
| Rybelsus 3 mg | Oral | S$150–250 | S$1,800–3,000 |
| Rybelsus 7 mg | Oral | S$200–300 | S$2,400–3,600 |
| Rybelsus 14 mg | Oral | S$300–450 | S$3,600–5,400 |
| Ozempic 0.25–0.5 mg | Injectable | S$250–350 | S$3,000–4,200 |
| Ozempic 1.0 mg | Injectable | S$350–500 | S$4,200–6,000 |
| Wegovy 2.4 mg | Injectable | S$500–700 | S$6,000–8,400 |
| Mounjaro 5–15 mg | Injectable | S$400–650 | S$4,800–7,800 |
Prices vary by provider, dispensing channel, and supply availability.
Medication cost alone doesn't tell the full story. Factor in all components of the treatment journey to understand your total investment.
| Component | GP/Specialist | noah™ |
|---|---|---|
| Initial consultation | S$50–350 | Included |
| Blood tests (baseline) | S$80–200 | Arranged as needed |
| Monthly medication | S$300–700 | From S$300 |
| Follow-up consultations | S$30–150 each | Included |
| Dose adjustment visits | S$30–150 each | Included |
| Delivery | N/A (collect in person) | Free |
| Route | Estimated Annual Cost |
|---|---|
| Private GP + pharmacy | S$5,000–7,500 |
| Specialist endocrinologist | S$6,000–10,000 |
| noah™ | From S$4,200 |
Understanding what's covered (and what isn't) prevents unpleasant surprises and helps you plan your finances.
Not covered for weight loss medications. MediSave can be used for approved chronic disease management, but weight loss is not a currently approved category.
Generally not covered. Most insurers classify weight loss medication as cosmetic/lifestyle. Some may cover related consultations if coded under diabetes or metabolic syndrome management.
Does not cover weight loss medications.
GLP-1 treatment is a long-term investment, so smart cost management matters. Here are practical approaches to managing the financial aspect.
Lower entry cost while you assess response. If effective at managing appetite, it may be sufficient without upgrading to injectable.
As patents expire over the coming years, generic versions will become available at significantly lower prices. The timeline varies by medication and market.
Not everyone needs the maximum dose. Your doctor may find that a moderate dose achieves your goals at lower cost.
noah™ and other providers offer subscription pricing that's typically lower than per-unit purchasing. Predictable monthly costs also help with budgeting.
Weight loss reduces costs associated with diabetes, hypertension, and other obesity-related conditions. The investment in weight loss medication may be offset by reduced future healthcare costs.
A cost-effectiveness lens can help contextualise the investment in weight loss medication.
| Condition | Estimated Annual Cost of Management (SGD) |
|---|---|
| Type 2 diabetes medications | S$1,200–4,800 |
| Hypertension medications | S$600–2,400 |
| Sleep apnoea (CPAP) | S$1,500–3,000 |
| Knee replacement (obesity-related) | S$15,000–30,000 (one-time) |
Preventing or delaying these conditions through weight loss can produce significant long-term savings.
The value of improved mobility, energy, self-confidence, and reduced disease risk is difficult to quantify but real and significant for most patients.
They're complex biological or pharmaceutical products requiring significant R&D investment. Limited generic competition (patents) keeps prices high. As competition increases and patents expire, prices are expected to decline.
We strongly advise against importing medications from unregulated overseas sources. Counterfeit GLP-1 products have been identified globally, and cold-chain requirements for injectables make unregulated supply chains particularly risky. HSA-registered products through licensed providers ensure safety.
Over time, yes. As more GLP-1/GIP products enter the market and patents expire, competition will drive prices down. Oral formulations also tend to be cheaper to manufacture than injectables.
Check with your HR department. Some companies offer flexible medical spending accounts that may cover prescription weight loss. Others may cover the doctor consultation even if medication isn't covered.
noah™ offers monthly subscription plans to make the cost more manageable. Contact noah™ for current pricing and plan options.
→ Return to pillar: Complete Guide to Medical Weight Loss in Singapore
This article is for informational purposes only and does not constitute medical advice. Prices are approximate and subject to change.
Articles featured on Noah are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider.
